RCM
RA Capital Management Portfolio holdings
AUM
$5.94B
1-Year Return
18.15%
This Quarter Return
-2.71%
1 Year Return
+18.15%
3 Year Return
+417.5%
5 Year Return
+458.13%
10 Year Return
+21,247.51%
AUM
$1.86B
AUM Growth
-$456M
(-20%)
Cap. Flow
-$292M
Cap. Flow
% of AUM
-15.67%
Top 10 Holdings %
Top 10 Hldgs %
79.17%
Holding
33
New
4
Increased
4
Reduced
3
Closed
8
Top Buys
| 1 |
ZGNX
Zogenix, Inc.
ZGNX
|
$64M |
| 2 |
PRVL
Prevail Therapeutics Inc. Common Stock
PRVL
|
$36.2M |
| 3 |
Stoke Therapeutics
STOK
|
$32.7M |
| 4 |
MYOV
Myovant Sciences Ltd.
MYOV
|
$27.2M |
| 5 |
X4 Pharmaceuticals
XFOR
|
$12.9M |
Top Sells
| 1 |
InflaRx
IFRX
|
$106M |
| 2 |
BioCryst Pharmaceuticals
BCRX
|
$70.5M |
| 3 |
SAGE
Sage Therapeutics
SAGE
|
$61.1M |
| 4 |
Axsome Therapeutics
AXSM
|
$50.3M |
| 5 |
KalVista Pharmaceuticals
KALV
|
$41.2M |
Sector Composition
| 1 | Healthcare | 97.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
BioCryst Pharmaceuticals
BCRX
$1.74B
| – | – |
-8,659,983
| Closed | -$70.5M |
|
|
27
InflaRx
IFRX
$106M
| – | – |
-2,810,708
| Closed | -$106M |
|
28
Iovance Biotherapeutics
IOVA
$796M
| – | – |
-2,610,510
| Closed | -$24.8M |
|
|
29
KalVista Pharmaceuticals
KALV
$765M
| – | – |
-1,441,070
| Closed | -$41.2M |
|
30
Moderna
MRNA
$9.45B
| – | – |
-1,513,929
| Closed | -$30.8M |
|
|
SAGE
31
DELISTED
Sage Therapeutics
SAGE
| – | – |
-384,001
| Closed | -$61.1M |
|
|
EIGR
32
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| – | – |
-80,515
| Closed | -$33.8M |
|
|
MNTA
33
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| – | – |
-2,563,657
| Closed | -$37.3M |
|